Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in elderly people. Currently, the diagnosis of PD is based on neurological examination, neuroimaging, and the response to dopaminergic medication. The diagnosis can be challenging, especially at early disease stages, when...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Tainá M., van Rumund, Anouke, Bruinsma, Ilona B., Wessels, Hans J. C. T., Gloerich, Jolein, Esselink, Rianne A. J., Bloem, Bastiaan R., Kuiperij, H. Bea, Verbeek, Marcel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647396/
https://www.ncbi.nlm.nih.gov/pubmed/30465235
http://dx.doi.org/10.1007/s12035-018-1426-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647396/
https://www.ncbi.nlm.nih.gov/pubmed/30465235
http://dx.doi.org/10.1007/s12035-018-1426-9

Ejemplares similares